SEC Form 4 · accession 0001209191-15-086399
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth W Locke
Officer — Chief Scientific Officer
Period of report
Dec 17, 2015
Accepted (ET)
Dec 21, 2015 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 17, 2015 | S | 598 | $1.26 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 293 shares acquired under the Issuer's employee stock purchase plan on May 29, 2015 and 305 shares acquired under the Issuer's employee stock purchase plan on November 30, 2015.